Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2013-10-10 Major Shareholding Noti…
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
SALE OF EXISTING SHARES BY SUBSTANTIAL SHAREHOLDERS AND RESUMPTION OF TRADING
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the sale of existing shares by substantial shareholders and the resumption of trading of the company's shares. It details the shareholding percentages before and after the sale, the parties involved, and the trading halt and resumption dates. There is no financial data, no detailed report, and the document is relatively short (3950 characters). It is clearly an announcement about a transaction involving shares by major shareholders, not a full financial report or earnings release. Therefore, the most appropriate classification is Major Shareholding Notification (MRQ).
2013-10-10 English
TRADING HALT
Regulatory Filings Classification · 95% confidence The document is a short announcement from CSPC Pharmaceutical Group Limited regarding a trading halt on its shares pending the release of an announcement about possible disposal of shares by controlling shareholders. It is only 1500 characters long and does not contain any financial data, detailed report, or regulatory certification. It is an official notice related to trading status rather than a financial report or management information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2013-10-10 English
EXCHANGE NOTICE - TRADING HALT
Regulatory Filings Classification · 95% confidence The document is a short exchange notice regarding a trading halt for CSPC Pharmaceutical Group Limited. It does not fit into specific categories like earnings, dividends, or reports. As it is a regulatory announcement regarding market activity that does not fall into the other defined categories, it is classified as a general regulatory filing.
2013-10-10 English
Monthly return of equity issuer on movements in securities for the month ended 30 September 2013
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/09/2013, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month. The document is about capital structure changes and share issuance details, which aligns with the category for updates on company fundraising, financing activities, or capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is sufficient and contains substantive data, not just an announcement or certification, so it is not RPA or RNS.
2013-10-03 English
DISPOSAL OF A NON WHOLLY-OWNED SUBSIDIARY
Capital/Financing Update Classification · 95% confidence The document is an announcement by CSPC Pharmaceutical Group Limited regarding a discloseable transaction involving the disposal of a 90% equity interest in a non wholly-owned subsidiary, Tianjin Cenway. It includes detailed financial information of the subsidiary, terms of the disposal agreement, consideration, and reasons for the disposal. The document references compliance with the Listing Rules and percentage ratios for discloseable transactions, indicating it is a regulatory announcement about a significant corporate transaction. It is not a full financial report, audit report, or earnings release, nor is it a call transcript or AGM material. The document is a formal announcement of a capital transaction (disposal of subsidiary interest) and fits the category of Capital/Financing Update (CAP). The length and detail confirm it is not a mere announcement of a report but a substantive disclosure of a transaction.
2013-09-25 English
ANNOUNCEMENT - DISTRIBUTION AND SUPPLY AGREEMENT
Capital/Financing Update Classification · 90% confidence The document is an announcement from CSPC Pharmaceutical Group Limited regarding the signing of a distribution and supply agreement for a pharmaceutical product in the U.S. It is a corporate announcement about a business agreement, not a financial report, regulatory filing, or management report. The document is short (2379 characters) and does not contain financial data or detailed analysis. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is a business update related to capital or financing activities, specifically a distribution agreement which can be considered a capital/financing update as it relates to the company's commercial operations and market entry. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2013-09-23 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.